Treating severe psoriasis: how to navigate safely between scylla and charybdis?
Paul
Carle F
CF
Clinical Research, Novartis Pharma AG, Basel, Switzerland.
D006801:Humans; D011701:PUVA Therapy / Q000009:adverse effects*; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology*; D012720:Severity of Illness Index; D012878:Skin Neoplasms / Q000139:chemically induced